Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Andrews

Showing results (611-620 of 2,043) with videos related to

Pageof 205
Sort By:
The Journal of Antimicrobial Chemotherapy|February 1, 1997
A reassessment of the in-vitro activity of colistin sulphomethate sodiumC R Catchpole, J M Andrews, N Brenwald, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 27, 2010
Heterophilic antibody interference in a chemiluminescent immunometric erythropoietin assayLaura Spruill, Mary A Constantin, Dorinda M Andrews, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1992
Concentrations of cefpodoxime in serum and bronchial mucosal biopsiesD R Baldwin, R Wise, J M Andrews, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1990
The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporinsR Wise, J M Andrews, J P Ashby, et al.
Acta Physiologica Scandinavica|March 11, 2000
Effect of nervous excitation on acid secretion in horsesA Sandin, F M Andrews, J A Nadeau, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1988
A comparison of the pharmacokinetics and tissue penetration of spiramycin and erythromycinJ Kavi, J M Webberley, J M Andrews, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1991
Comparative pharmacokinetic disposition of fluoroquinolones in the lungR Wise, D R Baldwin, J M Andrews, et al.
FEMS Microbiology Letters|June 15, 1994
Determination of OPC-17116, a new fluoroquinolone, in human alveolar macrophages and other biological matrices by high performance liquid chromatography (HPLC)J M Woodcock, J M Andrews, D Honeybourne, et al.
Journal of Substance Use and Addiction Treatment|June 10, 2025
Medicaid health home design and buprenorphine receipt, 2009-2020Christina M Andrews, Theodoros Giannouchos, Angela Rogers, et al.
Journal of Crohn'S & Colitis|September 30, 2014
Covert dose reduction is a distinct type of medication non-adherence observed across all care settings in inflammatory bowel diseaseRéme Mountifield, Jane M Andrews, Antonina Mikocka-Walus, et al.
Pageof 205

Showing results (611-620 of 2,043) with videos related to

Sort By:
Pageof 205
The Journal of Antimicrobial Chemotherapy|February 1, 1997
A reassessment of the in-vitro activity of colistin sulphomethate sodiumC R Catchpole, J M Andrews, N Brenwald, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 27, 2010
Heterophilic antibody interference in a chemiluminescent immunometric erythropoietin assayLaura Spruill, Mary A Constantin, Dorinda M Andrews, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1992
Concentrations of cefpodoxime in serum and bronchial mucosal biopsiesD R Baldwin, R Wise, J M Andrews, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1990
The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporinsR Wise, J M Andrews, J P Ashby, et al.
Acta Physiologica Scandinavica|March 11, 2000
Effect of nervous excitation on acid secretion in horsesA Sandin, F M Andrews, J A Nadeau, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1988
A comparison of the pharmacokinetics and tissue penetration of spiramycin and erythromycinJ Kavi, J M Webberley, J M Andrews, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1991
Comparative pharmacokinetic disposition of fluoroquinolones in the lungR Wise, D R Baldwin, J M Andrews, et al.
FEMS Microbiology Letters|June 15, 1994
Determination of OPC-17116, a new fluoroquinolone, in human alveolar macrophages and other biological matrices by high performance liquid chromatography (HPLC)J M Woodcock, J M Andrews, D Honeybourne, et al.
Journal of Substance Use and Addiction Treatment|June 10, 2025
Medicaid health home design and buprenorphine receipt, 2009-2020Christina M Andrews, Theodoros Giannouchos, Angela Rogers, et al.
Journal of Crohn'S & Colitis|September 30, 2014
Covert dose reduction is a distinct type of medication non-adherence observed across all care settings in inflammatory bowel diseaseRéme Mountifield, Jane M Andrews, Antonina Mikocka-Walus, et al.
Pageof 205